[HTML][HTML] Vero cell upstream bioprocess development for the production of viral vectors and vaccines

S Kiesslich, AA Kamen - Biotechnology advances, 2020 - Elsevier
The Vero cell line is considered the most used continuous cell line for the production of viral
vectors and vaccines. Historically, it is the first cell line that was approved by the WHO for the …

[HTML][HTML] Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response

CB Krubiner, RR Faden, RA Karron, MO Little… - Vaccine, 2021 - Elsevier
Zika virus, influenza, and Ebola have called attention to the ways in which infectious disease
outbreaks can severely–and at times uniquely–affect the health interests of pregnant women …

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines

N Hernandez, G Bucciol, L Moens, J Le Pen… - Journal of Experimental …, 2019 - rupress.org
Vaccination against measles, mumps, and rubella (MMR) and yellow fever (YF) with live
attenuated viruses can rarely cause life-threatening disease. Severe illness by MMR …

Historical perspectives on flavivirus research

MR Holbrook - Viruses, 2017 - mdpi.com
The flaviviruses are small single-stranded RNA viruses that are typically transmitted by
mosquito or tick vectors. These “arboviruses” are found around the world and account for a …

The present and future of yellow fever vaccines

CA Hansen, ADT Barrett - Pharmaceuticals, 2021 - mdpi.com
The disease yellow fever (YF) is prevented by a live-attenuated vaccine, termed 17D, which
has been in use since the 1930s. One dose of the vaccine is thought to give lifelong (35+ …

Current status and future prospects of yellow fever vaccines

AS Beck, ADT Barrett - Expert review of vaccines, 2015 - Taylor & Francis
Yellow fever 17D vaccine is one of the oldest live-attenuated vaccines in current use that is
recognized historically for its immunogenic and safe properties. These unique properties of …

Cell culture-derived tilapia lake virus-inactivated vaccine containing montanide adjuvant provides high protection against viral challenge for tilapia

W Zeng, Y Wang, H Hu, Q Wang, SM Bergmann… - Vaccines, 2021 - mdpi.com
Tilapia lake virus (TiLV) is a newly emerging pathogen responsible for high mortality and
economic losses in the global tilapia industry. Currently, no antiviral therapy or vaccines are …

Modeling assumptions, optimal control strategies and mitigation through vaccination to zika virus

N Sharma, R Singh, J Singh, O Castillo - Chaos, Solitons & Fractals, 2021 - Elsevier
Zika virus is amongst the deadly viruses still prevalent in more than 50 countries around the
world. It is amosquitoes-borne disease that spread at fast rate in 2016. Zika virus belongs to …

Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture

TP Pato, MCO Souza, DA Mattos, E Caride, DF Ferreira… - Vaccine, 2019 - Elsevier
Yellow fever (YF) is a high-lethality viral disease, endemic in tropical regions of South
America and Africa, with a population of over 900 million people under risk. A highly …

Safety and immunogenicity of different 17DD yellow fever vaccines in golden-headed tamarins (Leontopithecus chrysomelas): Inhibition of viremia and RNAemia after …

AT Silva-Fernandes, SB Moreira, LP Gaspar… - Vaccine, 2025 - Elsevier
Yellow fever (YF) is a viral disease that affects both humans and non-human primates
(NHPs). Neotropical monkeys are more severely stricken by YF and the impact of the …